Sign Out
Pregnancy: No clinical data on exposed pregnancies are available. The potential risk for humans is unknown.
Women of child-bearing potential should avoid pregnancy during treatment with dabigatran etexilate (Pradaxa) and when pregnant, women should not be treated with dabigatran etexilate (Pradaxa) unless the expected benefit is greater than the risk.
Lactation: No clinical data are available. As a precaution, breastfeeding should be stopped.
Fertility: No clinical data available. Non-clinical reproductive studies did not show any adverse effects on fertility or postnatal development of the neonate.
Continue with Google